Alodokter is expecting... a growth spurt, with its recent acquisition of pregnancy app Diary Bunda from Marubeni!

While the official numbers are hush-hush, DealStreetAsia notes that Alodokter recently allocated shares worth $6M to Optima Health, a Marubeni subsidiary. Now, onto the other vitals!

‍

🤔 Who’s the buyer?

It’s Alodokter! The Indonesian digital health app enables convenient access to healthcare services, teleconsultations, and health management tools.

• Their AI-powered symptom checker allows users to input their symptoms and receive instant personalized recommendations about potential health conditions!
• They also offer health articles and resources curated by medical professionals, to empower users to make informed decisions about their well-being.

Founded in 2014, they’ve since:

• Gained support from 1,500 hospital and clinic partners, 500 pharmacies, and 1,000 doctors
• Grown 20% YoY in 2022
• Drawn 30M monthly active users

They’re supported by Beacon VC, Sequis Life, Golden Gate Ventures and many others. Now, they’ve acquired Diary Bunda from Japanese conglomerate Marubeni Corp.

‍

🔙 Rewind on Diary Bunda

The mobile app is an all-in-one support system for pregnant mothers. It offers:

• Personalized tracking of pregnancy and baby progress, providing information about changes that occur in the mother's body and the developing baby
• Additional educational content to help distinguish facts from myths
• Discussion forums to share experiences and knowledge

Since its launch in 2020, they claim to have garnered over 600k users throughout Indonesia!

‍

🔜  Incoming growth spurt?

What’s next for Diary Bunda users? A seamless integration of Alodokter’s features into one app, along with expansion on current features, Alodokter ensures that the app remains a reliable and comprehensive source for the community of Indonesian mothers.